Kaiser Permanente

Fontana, California 92335

0 studies enrolling now · 4 studies all time

What they study most

HER2-Positive Primary Breast Cancer, Leukemia, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Residual Invasive Breast Cancer, Systemic Lupus Erythematosus

Studies at this site

• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia — Completed
• A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) — Running, not enrolling
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early